A licensing agreement is one way forward Dr. That might be a reasonable option if the royalty stream was robust (and a good percentage). The other way forward (and maybe more likely with the current mgt) is a capital raising. And, get the money required to set up sales, marketing and distribution. This is a very likely prospect in the US following FDA approval. That is a "comfortable" trigger point for US investors. GLTA
A licensing agreement is one way forward Dr. That might be a...
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.53 |
Change
-0.200(7.33%) |
Mkt cap ! $172.2M | |||
| Open | High | Low | Value | Volume |
| $2.59 | $2.61 | $2.53 | $1.062M | 413.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 15328 | $2.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.54 | 812 | 1 |
View Market Depth
| Last trade - 16.10pm 05/08/2024 (20 minute delay) ? |
| AVH (ASX) Chart |